Chloe Orkin

Most people living with HIV can take a single daily pill or injections every two months, but many long-time HIV survivors who were put on early drugs developed resistance, so they must take many pills multiple times a day.

Now, a new pill made by Gilead Sciences may mean they can simplify their treatment regimen.

Chloe Orkin of Queen Mary University of London co-authored the study.

The particular pill

excitement is for this population who's been left behind by medical advances.

This new daily pill combines two drugs and appears to be as effective as the complex treatments.

Orkin says the drug could be available in many countries within a year.

Gabriela Emanuel, NPR News.